Anfield Capital Management’s APEX HealthCare ETF APXH Stock Holding History

Anfield Capital Management’s Portfolio APXH Stock Details APXH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-63,533	Closed	-$564K	–	94
2022 Q4	$564K	Sell	63,533 -4,479	-7%	-$38.5K	0.28%	47
2022 Q3	$535K	Sell	68,012 -590	-0.9%	-$5.02K	0.26%	49
2022 Q2	$578K	Buy	68,602 +1,698	+3%	+$14.8K	0.26%	50
2022 Q1	$628K	Buy	+66,904	New	+$616K	0.23%	52

Anfield Capital Management's APXH Position: Q1 2023 in Review

Anfield Capital Management sold out of APEX HealthCare ETF (APXH) in Q1 2023, closing a stake of 63,533 shares — an estimated $564K sold.

Anfield Capital Management first reported a position in APXH in Q1 2022 and held it in 4 quarters. The position peaked at $628K in Q1 2022. 0 funds tracked by Wall St. Rank hold APXH as of Q1 2023.

Anfield Capital Management reported no remaining APEX HealthCare ETF position as of Q1 2023 after selling out during the quarter.
Anfield Capital Management sold 63,533 APEX HealthCare ETF shares in Q1 2023, an estimated $564K.
Anfield Capital Management first reported a position in APEX HealthCare ETF in Q1 2022 and held it in 4 quarters.
Anfield Capital Management's APEX HealthCare ETF position peaked at $628K in Q1 2022.
0 funds tracked by Wall St. Rank held APEX HealthCare ETF as of Q1 2023.

Based on Anfield Capital Management's 13F filing for Q1 2023, filed 4 May 2023.